Marshall Wace LLP Purchases New Position in Enhabit, Inc. (NYSE:EHAB)

Marshall Wace LLP acquired a new position in shares of Enhabit, Inc. (NYSE:EHAB - Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 217,616 shares of the company's stock, valued at approximately $1,941,000. Marshall Wace LLP owned approximately 0.43% of Enhabit at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Gladius Capital Management LP purchased a new position in shares of Enhabit in the second quarter valued at $31,000. Allspring Global Investments Holdings LLC purchased a new position in Enhabit during the 1st quarter valued at about $44,000. Canada Pension Plan Investment Board acquired a new position in Enhabit during the second quarter worth about $93,000. ProShare Advisors LLC purchased a new stake in shares of Enhabit in the first quarter valued at about $118,000. Finally, Family Firm Inc. acquired a new stake in shares of Enhabit in the first quarter valued at approximately $124,000.

Analyst Ratings Changes

Separately, Bank of America cut their price objective on Enhabit from $9.00 to $8.00 and set an "underperform" rating for the company in a research report on Thursday, June 27th. One equities research analyst has rated the stock with a sell rating and six have issued a hold rating to the stock. Based on data from MarketBeat, the company has an average rating of "Hold" and a consensus target price of $9.35.

Enhabit Trading Down 1.2 %

Shares of NYSE:EHAB traded down $0.09 during trading on Friday, reaching $7.48. The stock had a trading volume of 403,131 shares, compared to its average volume of 614,480. The company has a quick ratio of 1.48, a current ratio of 1.48 and a debt-to-equity ratio of 0.73. The stock has a market cap of $375.17 million, a P/E ratio of -4.51 and a beta of 1.81. The business has a fifty day moving average price of $8.36 and a 200-day moving average price of $9.20. Enhabit, Inc. has a fifty-two week low of $7.12 and a fifty-two week high of $11.74.

Enhabit (NYSE:EHAB - Get Free Report) last issued its quarterly earnings results on Tuesday, August 6th. The company reported $0.07 earnings per share for the quarter, topping analysts' consensus estimates of $0.05 by $0.02. The company had revenue of $260.60 million for the quarter, compared to analyst estimates of $265.99 million. Enhabit had a positive return on equity of 1.61% and a negative net margin of 0.84%. During the same quarter in the prior year, the company posted $0.04 EPS. As a group, analysts anticipate that Enhabit, Inc. will post 0.26 earnings per share for the current fiscal year.

Insider Activity

In related news, Director Jeffrey Bolton purchased 5,000 shares of the business's stock in a transaction on Thursday, August 22nd. The shares were bought at an average price of $8.01 per share, with a total value of $40,050.00. Following the completion of the purchase, the director now directly owns 78,877 shares in the company, valued at approximately $631,804.77. This trade represents a 0.00 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at this hyperlink. Corporate insiders own 1.90% of the company's stock.

Enhabit Company Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.